Cargando…

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature

BACKGROUND: Mifepristone, also known as RU-486, is an anti-progestational steroid with similar chemical structure to anabolic steroids. Given as a single dose in conjunction with misoprostol, mifepristone is used to induce medical abortion. Mifepristone administered chronically at a higher dose is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ault, Taylor A., Braxton, David R., Watson, Rebecca A., Marcus, Alan O., Fong, Tse-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894739/ https://www.ncbi.nlm.nih.gov/pubmed/36732814 http://dx.doi.org/10.1186/s13256-022-03696-x

Ejemplares similares

THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)

Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome
por: Díaz-Castro, Francisco, et al.
Publicado: (2020)

Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
por: Sai, Katta, et al.
Publicado: (2019)

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome
por: Moraitis, Andreas G., et al.
Publicado: (2016)

Global clinical response in Cushing’s syndrome patients treated with mifepristone
por: Katznelson, Laurence, et al.
Publicado: (2014)

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations
por: Brown, David R., et al.
Publicado: (2020)

The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome
por: Rowell, Jennifer Voigt
Publicado: (2021)

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

SUN-186 Case Report: Mifepristone Taper in an Individual with Equivocal Cushing’s Syndrome Screening Tests
por: Martin, Christopher, et al.
Publicado: (2020)

Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
por: Wallia, Amisha, et al.
Publicado: (2013)

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
por: Chang, Alice Y, et al.
Publicado: (2021)

Mifepristone: An Uncommon Cause of Drug-Induced Liver Injury
por: Shah, Ishani, et al.
Publicado: (2019)

Correction to: Mifepristone: An Uncommon Cause of Drug-Induced Liver Injury
por: Shah, Ishani, et al.
Publicado: (2020)

Case series and review of Ayurvedic medication induced liver injury
por: Karousatos, Christopher M., et al.
Publicado: (2021)

Sustained weight loss in patients treated with mifepristone for Cushing’s syndrome: a follow-up analysis of the SEISMIC study and long-term extension
por: Fein, Henry G., et al.
Publicado: (2015)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature
por: Cossu, Giulia, et al.
Publicado: (2015)

A Pilot Study of Mifepristone in Combat-Related PTSD
por: Golier, Julia A., et al.
Publicado: (2012)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

MON-413 First Reported Case of Combined High-Dose Mifepristone Therapy and Oral Contraceptive in Inducing Reversible Cholestatic Hepatitis in a Patient with Cushing Disease
por: Youssef, Nancy, et al.
Publicado: (2019)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Acute pancreatitis associated with Cushing syndrome – A case report and literature review
por: Bouali, M., et al.
Publicado: (2021)

Factitious cushing’s syndrome with unusual presentation: a case report and literature review
por: Zeer, Almotazbellah M. M., et al.
Publicado: (2023)

ACTH-Producing Neuroendocrine Carcinoma of the Liver with Cushing's Syndrome
por: Sandozi, Mudassar, et al.
Publicado: (2023)

Streptomyces infection in Cushing syndrome: A case report and literature review
por: Ataiekhorasgani, Masoud, et al.
Publicado: (2014)

Ectopic Cushing Syndrome in Adenocarcinoma of the Lung: Case Report and Literature Review
por: Al-Zakhari, Rana, et al.
Publicado: (2021)

Alcohol-induced Cushing syndrome: report of eight cases and review of the literature
por: Surani, Asif, et al.
Publicado: (2023)

Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
por: Parker, John C., et al.
Publicado: (2021)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis
por: Xue, Hui-Ling, et al.
Publicado: (2016)

Occult Carcinoid Causes Cushing’s Syndrome
por: Meftali, Sabrina, et al.
Publicado: (2021)

X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor–Progesterone–Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface
por: Colucci, Jennifer K., et al.
Publicado: (2013)

Pregnancy during the course of Cushing’s syndrome: a case report and literature review
por: Ildefonso-Najarro, Sofia Pilar, et al.
Publicado: (2020)

Cushing’s Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature
por: Zhang, Da, et al.
Publicado: (2021)

Endocrine hypertension – Cushing's syndrome
por: Singh, Yashpal, et al.
Publicado: (2011)

An infant with Cushing syndrome
por: Sng, Andrew, et al.
Publicado: (2015)

The dopaminergic control of Cushing’s syndrome
por: Pivonello, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vtq78gmi6fvsd0f9f34epdbbjc